Viewing Study NCT03126461


Ignite Creation Date: 2025-12-24 @ 1:06 PM
Ignite Modification Date: 2025-12-29 @ 4:46 AM
Study NCT ID: NCT03126461
Status: WITHDRAWN
Last Update Posted: 2020-08-20
First Post: 2017-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
Sponsor: University of Texas Southwestern Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module